phenylchlorosulfate | 16475-29-9

• 物质功能分类: 化学试剂 - 有机试剂 - 甲苯磺酸酯
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: phenylchlorosulfate
• 英文别名: phenyl sulphuryl chloride；phenyl sulfurochloridate；phenyl sulfochloridate；phenyl chlorosulfate；chlorosulfuric acid phenyl ester；Schwefelsaeure-phenylester-chlorid；Chlorosulfuric acid, phenyl ester；chlorosulfonyloxybenzene
• CAS: 16475-29-9
• 化学式: C₆H₅ClO₃S
• 分子量: 192.623
• InChiKey: XBXHEDNNWSJZPK-UHFFFAOYSA-N

物化性质

• 熔点：
  179 °C
• 沸点：
  221-222 °C(Press: 735 Torr)
• 密度：
  1.489±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  51.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  phenylchlorosulfate 以 四氢呋喃 、 乙醚 为溶剂， 反应 3.5h， 生成 3-methyl-1-(phenoxysulfonyl)-1H-imidazol-3-ium trifluoromethanesulfonate
  参考文献：
  名称：

  Preparation of trifluoroethyl- and phenyl-protected sulfates using sulfuryl imidazolium salts

  摘要：

  Sulfuryl imidazolium salts (SIS's), a new class of sulfating agents, were prepared bearing the trifluoroethyl (TFE) and phenyl groups, two functionalities that have been used for the protection of sulfate monoesters, by subjecting the corresponding sulfonyl imidazoles with methyl triflate. In contrast, SIS's bearing the electron donating neopentyl and isobutyl groups, two moieties that have also been used for the protection of sulfates, were found to be unstable and could not be isolated though SIS's bearing electron donating aryl groups, such as a p-methoxyphenyl or p-thiomethylphenyl group were readily prepared and are stable compounds. In most instances, TFE-protected phenolic and carbohydrate sulfates were obtained in good yield by reaction of the corresponding SIS's with steroids and carbohydrates. Phenyl-protected carbohydrates were also readily prepared using the corresponding SIS's. Those SIS's having a methyl group at the 2-position of the imidazole ring were, in general, superior sulfating agents to those, which lacked a methyl group at this position. The use of SIS's to prepare TFE-protected sulfates represents a significant improvement of the previous reported procedure, which involved treating unprotected sulfates with trifluorodiazoethane. The TFE protecting group was removed from steroidal sulfates and secondary sulfates in carbohydrates in high yields using NaN(3) in warm DMF, conditions that are less vigorous than those previously reported for removing this group. Deprotection of TFE-protected 6-sulfated carbohydrates using NaN3 in warm DMF proceeded in lower yields due to partial desulfation. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2010.11.085
• 作为产物：
  描述：

  sodium phenoxide 在 磺酰氯 、 苯 作用下， 生成 phenylchlorosulfate
  参考文献：
  名称：

  Battegay; Denivelle, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1932, vol. 194, p. 1505

  摘要：

  DOI：
• 作为试剂：
  描述：

  (4-乙烯基苯)磺酰胺 、 三乙胺 在 phenylchlorosulfate 作用下， 以 乙腈 为溶剂， 以70%的产率得到((4-vinylphenyl)sulfonyl)azanesulfonyl chloride triethylamine salt
  参考文献：
  名称：

  방향족 고리를 포함하는 화합물 및 이를 포함하는 중합체

  摘要：

  这份规范涉及含有芳香环的化合物以及包含这些化合物的聚合物。

  公开号：

  KR20180049949A

文献信息

• DERIVATIVES OF RELEBACTAM AND USES THEREOF
  申请人：ARIXA PHARMACEUTICALS, INC.

  公开号：US20200102307A1

  公开（公告）日：2020-04-02

  Derivatives of relebactam, therapeutic methods of using the derivatives of relebactam, particularly in combination with β-lactam antibiotics and pharmaceutical compositions thereof are disclosed. The derivatives of relebactam are suitable for oral administration.

  Relebactam的衍生物、使用Relebactam的衍生物的治疗方法，特别是与β-内酰胺类抗生素结合使用以及其制药组合物已被披露。Relebactam的衍生物适合口服给药。
• Beta-lactamase inhibitors and uses thereof
  申请人：ARIXA PHARMACEUTICALS, INC.

  公开号：US10085999B1

  公开（公告）日：2018-10-02

  β-Lactamase inhibiting compounds, therapeutic methods of using the β-lactamase inhibiting compounds, particularly in combination with β-lactam antibiotics and pharmaceutical compositions thereof are disclosed. The β-lactamase inhibiting compounds are suitable for oral administration.

  β-内酰胺酶抑制化合物，使用β-内酰胺酶抑制化合物的治疗方法，特别是与β-内酰胺类抗生素结合以及其制药组合物被披露。这些β-内酰胺酶抑制化合物适合口服给药。
• Synthesis of Aryl Sulfonamides via Palladium-Catalyzed Chlorosulfonylation of Arylboronic Acids
  作者：J. Robb DeBergh、Nootaree Niljianskul、Stephen L. Buchwald

  DOI：10.1021/ja405949a

  日期：2013.7.24

  A palladium-catalyzed method for the preparation of sulfonamides is described. The process exhibits significant functional group tolerance and allows for the preparation of a number of arylsulfonyl chlorides and sulfonamides under mild conditions.

  描述了一种用于制备磺酰胺的钯催化方法。该工艺表现出显着的官能团耐受性，并允许在温和条件下制备多种芳基磺酰氯和磺酰胺。
• AZTREONAM DERIVATIVES AND USES THEREOF
  申请人：ARIXA PHARMACEUTICALS, INC.

  公开号：US20190100516A1

  公开（公告）日：2019-04-04

  Disclosed herein are aztreonam derivatives, therapeutic methods of using the aztreonam derivatives, particularly in combination with β-lactamase inhibitors, and pharmaceutical compositions thereof. The aztreonam derivatives can be administered orally to provide orally bioavailable aztreonam.

  本文披露了阿特雷纳姆衍生物，使用阿特雷纳姆衍生物的治疗方法，特别是与β-内酰胺酶抑制剂结合使用的方法，以及它们的药物组成物。这些阿特雷纳姆衍生物可以口服给药，从而提供口服可利用的阿特雷纳姆。
• [EN] SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES<br/>[FR] SYSTÈMES DE LIAISON CONTENANT UN SULFONAMIDE POUR CONJUGUÉS DE MÉDICAMENTS
  申请人：CT FOR DRUG RES AND DEV

  公开号：WO2015095953A1

  公开（公告）日：2015-07-02

  Sulfonamide-containing linkage systems for release of payload compounds from an attached targeting moiety in drug conjugates. The conjugates have the formula of [(P)-(L)]m-(T), wherein (P) is a payload compound, (L) is a linker, (T) is a targeting moiety and m is an integer from 1- to 10. Also provided are pharmaceutical compositions comprising such conjugates and there use in treating cancer.

  含有磺胺基的连接系统，用于从药物共轭物中的附加靶向基团释放有效成分。这些共轭物的化学式为[(P)-(L)]m-(T)，其中(P)代表有效成分，(L)代表连接剂，(T)代表靶向基团，m为1到10之间的整数。还提供了包含这种共轭物的药物组合物，并用于治疗癌症。